Coming October 2: SITC releases abstract titles with each presenting author’s institution (nearly 1,300 last year). We’ll add them to this guide once they’re out.

Pharma and biotech companies at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

35 pharma and biotech companies are at SITC 2026 — 24 presentations on the program and 13 with a booth in the exhibit hall. Most represented: AstraZeneca (4 on the program), Marengo Therapeutics (2 on the program), Merck & Co. (2 on the program). 24 of them have their own page in this guide. As of Sep 29, 2026.

All 242 organizations at SITC 2026 →

Showing 1–10 of 35 organizations

Organization	SITC 2026 Attendance
AstraZeneca Cambridge, United Kingdom
astrazeneca.com Large pharma Global biopharmaceutical company that discovers, develops and sells prescription medicines, with oncology among its main therapy areas.	Booth Exhibiting at Booth 801 Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm Workshop Wed Nov 4 2:00pm–5:00pm Biotech Regulatory Roundtable 2:00pm–2:10pmOpening Remarks: SITC Biotech Initiative: A Quest for 100 Novel Agents 2:10pm–2:55pmPanel Discussion 1: Conversations with FDA Oncology Leaders on Hot Topics 2:55pm–3:10pmNetworking Break 3:10pm–3:55pmPanel Discussion 2: Biomarker Discovery and Digital AI 3:55pm–4:10pmNetworking Break #2 4:10pm–4:55pmPanel Discussion 3: Regulatory Framework for New IO Agents 4:55pm–5:00pmClosing Remarks Workshop Wed Nov 4 2:10pm–2:55pm Panel Discussion 1: Conversations with FDA Oncology Leaders on Hot Topics Encanto AB Regulatory Session Wed Nov 4 4:10pm–4:55pm Panel Discussion 3: Regulatory Framework for New IO Agents Encanto AB Regulatory · New agents Talk Thu Nov 5 10:20am–10:30am Part of Session II: Immune Cell Engagers and Bispecifics From Bench to Bispecific: The Rilvegostomig Program at a Glance Valley of the Sun Ballroom New agents Session Thu Nov 5 12:00pm–1:30pm Collaborating with Industry Encanto AB Talk Thu Nov 5 4:30pm–5:00pm Part of Session II – Breakout Sessions Breakout Table: Interfacing with Industry (Biotech Grants) Encanto AB
Marengo Therapeutics Cambridge, MA
marengotx.com Biotech Clinical-stage biotech developing antibodies that target TCR V-beta chains to selectively activate T cell subsets against cancer.	Workshop Wed Nov 4 2:00pm–5:00pm Biotech Regulatory Roundtable 2:00pm–2:10pmOpening Remarks: SITC Biotech Initiative: A Quest for 100 Novel Agents 2:10pm–2:55pmPanel Discussion 1: Conversations with FDA Oncology Leaders on Hot Topics 2:55pm–3:10pmNetworking Break 3:10pm–3:55pmPanel Discussion 2: Biomarker Discovery and Digital AI 3:55pm–4:10pmNetworking Break #2 4:10pm–4:55pmPanel Discussion 3: Regulatory Framework for New IO Agents 4:55pm–5:00pmClosing Remarks Workshop Wed Nov 4 4:10pm–4:55pm Panel Discussion 3: Regulatory Framework for New IO Agents Encanto AB Regulatory · New agents Workshop Wed Nov 4 4:55pm–5:00pm Closing Remarks Encanto AB Session Thu Nov 5 12:00pm–1:30pm Setting Up a Successful Biotech (Midsize Pharma and Small Startups) Encanto AB Regulatory Workshop Thu Nov 5 5:00pm–9:00pm Launching Biotech Startups: Funding, Pitching, Partnerships 5:00pm–5:45pmWelcome Reception 5:55pm–6:55pmHigh-Impact Talks from Pharma Leaders 6:55pm–7:15pmPanel 7:00pm–7:50pmFinancing and Partnership Panel 8:00pm–9:00pmClosing Networking Reception
Merck & Co. Rahway, NJ
merck.com Large pharma Global pharmaceutical company, known as MSD outside the US and Canada, running a broad oncology research and clinical development program.	Booth Exhibiting at Booth 1228 Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm Session Wed Nov 4 3:10pm–3:55pm Panel Discussion 2: Biomarker Discovery and Digital AI Encanto AB Biomarkers · AI & data Talk Thu Nov 5 5:55pm–6:15pm Part of High-Impact Talks from Pharma Leaders Advancing External Innovation: Merck’s Oncology Strategy Regulatory Session Thu Nov 5 6:55pm–7:15pm Panel Session Fri Nov 6 3:55pm–5:30pm Biotech Session: The Next Generation of Off-the-Shelf IO Halls BC Cell therapy 3:55pm–4:10pmNext-gen T Cell Engagers 4:10pm–4:25pmIn vivo Cell Therapy Platforms for CancerEli Lilly and Company 4:25pm–4:40pmAllogeneic Cell TherapiesAllogene Therapeutics 4:40pm–5:00pm2 abstract presentations — titles not yet released 5:00pm–5:30pmIn Vivo - Ex Vivo DebateKite Pharma, Massachusetts Institute of Technology, Roswell Park Comprehensive Cancer Center, Azalea Therapeutics
Bristol Myers Squibb Princeton, NJ
bms.com Large pharma Global pharmaceutical company whose immuno-oncology medicines include the checkpoint inhibitors nivolumab and ipilimumab.	Talk Thu Nov 5 1:45pm–1:55pm Part of Session III: ADC/iADC Iza-bren: BMS's First Bispecific ADC, and Pumitamig, the PD-L1×VEGF-A Bispecific Antibody Valley of the Sun Ballroom New agents Talk Thu Nov 5 6:35pm–6:55pm Part of High-Impact Talks from Pharma Leaders BMS’s Approach to Scientific Opportunity and Strategic Partnership Regulatory Session Thu Nov 5 6:55pm–7:15pm Panel
Johnson & Johnson New Brunswick, NJ
jnj.com Large pharma Pharmaceutical business of Johnson & Johnson, formerly Janssen, developing oncology medicines including bispecific antibodies and cell therapy.	Talk Thu Nov 5 11:30am–11:50am Part of Session II: Immune Cell Engagers and Bispecifics Debate (Cell Therapy vs. Engagers) Valley of the Sun Ballroom Cell therapy · New agents Talk Thu Nov 5 10:05am–10:20am Part of Session II: Immune Cell Engagers and Bispecifics Introduction/History/Approved Drugs/Almost Approved - Overview Talk Valley of the Sun Ballroom New agents Workshop Thu Nov 5 5:00pm–9:00pm Launching Biotech Startups: Funding, Pitching, Partnerships 5:00pm–5:45pmWelcome Reception 5:55pm–6:55pmHigh-Impact Talks from Pharma Leaders 6:55pm–7:15pmPanel 7:00pm–7:50pmFinancing and Partnership Panel 8:00pm–9:00pmClosing Networking Reception
Allogene Therapeutics South San Francisco, CA
allogene.com Biotech Clinical-stage company developing allogeneic, off-the-shelf CAR T cell therapies.	Talk Thu Nov 5 9:05am–9:15am Part of Session I: Cell Therapies and Technologies Advancing a First-in-Class Allogeneic CAR T Approach in Renal Cell Carcinoma: Clinical Experience from the TRAVERSE Study Valley of the Sun Ballroom Cell therapy · Clinical Talk Fri Nov 6 4:25pm–4:40pm Part of Session 107b: Biotech Session: The Next Generation of Off-the-Shelf IO Allogeneic Cell Therapies Halls BC Cell therapy
Genmab Copenhagen, Denmark
genmab.com Biotech Danish antibody company with marketed cancer medicines, developing bispecific antibodies and antibody-drug conjugates.	Talk Thu Nov 5 10:40am–10:50am Part of Session II: Immune Cell Engagers and Bispecifics Industry Talk with Clinical Data Valley of the Sun Ballroom New agents · Clinical Talk Thu Nov 5 2:25pm–2:35pm Part of Session III: ADC/iADC Industry Talk with Clinical Data Valley of the Sun Ballroom New agents · Clinical
Iovance Biotherapeutics San Carlos, CA
iovance.com Biotech Develops and commercializes tumor-infiltrating lymphocyte (TIL) cell therapies for people with solid tumors.	Booth Exhibiting at Booth 700 Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm Session Wed Nov 4 4:10pm–4:55pm Panel Discussion 3: Regulatory Framework for New IO Agents Encanto AB Regulatory · New agents Workshop Fri Nov 6 1:10pm–1:25pm Tech Talk - Iovance Biotherapeutics 1 Exhibit Hall Presentation Stage Workshop Sat Nov 7 6:55pm–7:10pm Tech Talk - Iovance Biotherapeutics 2 Exhibit Hall Presentation Stage
Replimune Woburn, MA
Replimune.com Biotech Develops oncolytic immunotherapies designed to trigger a systemic, lasting anti-tumor immune response.	Booth Exhibiting at Booth 401 Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm Session Thu Nov 5 12:00pm–1:30pm Industry: Building Your Career in Industry (Startup and Midsize Pharma) Encanto AB Workshop Thu Nov 5 7:00pm–8:00pm Early Career Scientist Speed Mentoring 7:00pm–8:00pmSpeed Mentoring - Group Mentoring 7:00pm–7:30pmSpeed Mentoring - One-on-One 7:30pm–8:00pmSpeed Mentoring - One-on-One 2 Session Sat Nov 7 12:30pm–1:30pm Rapid Oral - Clinical 2 301BC Clinical 12:30pm–1:24pm6 abstract presentations — titles not yet released
AT Ankyra Therapeutics
Biotech Develops anchored immunotherapies designed to keep cytokine drugs at the tumor injection site.	Session Thu Nov 5 12:00pm–1:30pm Transitioning from Academia to Industry Encanto AB Workshop Thu Nov 5 7:00pm–8:00pm Early Career Scientist Speed Mentoring 7:00pm–8:00pmSpeed Mentoring - Group Mentoring 7:00pm–7:30pmSpeed Mentoring - One-on-One 7:30pm–8:00pmSpeed Mentoring - One-on-One 2 Session Fri Nov 6 12:30pm–1:30pm Rapid Oral - Clinical 1 301BC Clinical 12:30pm–1:24pm6 abstract presentations — titles not yet released